Managers / Q1 2026
Gagnon Advisors, LLC
CIK 0001599466 · 1370 AVENUE OF THE AMERICAS, 26TH FLOOR, NEW YORK, NY, 10019 · 212-554-5050
Summary
Gagnon Advisors, LLC reported $136M in U.S.-listed holdings across 22 positions for Q1 2026.
Its largest position, EPD, represents 9.5% of the portfolio.
Compared with Q4 2025, the fund opened 2 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 65.9% · $90M
- Other · 9.6% · $13M
- MLP · 9.5% · $13M
- REIT · 7.7% · $11M
- ETP · 7.1% · $10M
- Other · 0.2% · $314,204
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +95.6K | 95.6K | +$10M | $10M |
| HNGEHINGE HEALTH INC | NEW | +80.8K | 80.8K | +$3M | $3M |
| ALAIR LEASE CORP | SOLD OUT | −196.5K | 0 | −$13M | $0 |
| TMCITREACE MED CONCEPTS INC | SOLD OUT | −1.53M | 0 | −$4M | $0 |
| NVDANVIDIA CORPORATION | SOLD OUT | −16.6K | 0 | −$3M | $0 |
| HZOMarineMax Inc | TRIMMED | −97.2K | 97.2K | −$2M | $3M |
| AMPLAMPLITUDE INC | ADDED | +177.8K | 635.0K | −$963,904 | $4M |
| FRSHFRESHWORKS INC | ADDED | +211.3K | 776.2K | −$686,786 | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $136M | 22 | Apr 22, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $158M | 23 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $162M | 24 | Nov 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $149M | 24 | Jul 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $142M | 28 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $156M | 26 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $155M | 27 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $131M | 27 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $115M | 27 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $114M | 26 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $120M | 28 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $149M | 29 | Aug 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $149M | 28 | Apr 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $148M | 29 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $154M | 32 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $165M | 33 | Aug 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $217M | 33 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $252M | 34 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $252M | 35 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $263M | 32 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $474M | 30 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $222M | 29 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $163M | 30 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $139M | 26 | Aug 14, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2020 | $107M | 27 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $178M | 32 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $161M | 32 | Nov 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $175M | 33 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $175M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $142M | 31 | Jan 18, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.